Fibrinous Peritonitis in a Patient with Rheumatoid Arthritis

McRorie E.R. , Wright R.A. , Errington M.L. , Luqmani R.A. Rheumatoid constrictive pericarditis. Br Rheumatol 1997; 36: 100–3

Clegg D.O. , Furst D.E. , Tolman K.G. , Pogue R. Acute, reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis. J Rheumatol 1989; 16: 1123–6

Kujala G.A. , Shamma'a J.M. , Chang W.L. , Brick J.E. Hepatitis with bridging fibrosis and reversible hepatic insufficiency in a female with rheumatoid arthritis taking methotrexate. Arthritis Rheum 1990; 33: 1037–41

Gurry J.F. , Cunningham I.G. , Brooke B.N. Betablockers and fibrinous peritonitis. BMJ 1975; ii: 498

Thompson R.P. , Jackson B.T. Beta-blockers and fibrinous peritonitis. BMJ 1975; ii: 747

Allan D. , Cade D. Delayed fibrinous peritonitis after practolol treatment. BMJ 1975; iv: 40

Windsor W.O. , Durrein F. , Dyer N.H. Fibrinous peritonitis: a complication of practolol therapy. BMJ 1975; ii: 68